none8The widely used Monte Carlo simulation code FLUKA has been utilized to prototype a solid target for the production of 89Zr, by irradiation of a metallic 89Y target foil in a 16.5 MeV proton biomedical cyclotron, through the reaction 89Y(p, n)89Zr. Simulations were performed with and without an Al energy degrader. In the setup of the geometry of the target, state of the art support tools, like SimpleGeo, were used for accurate, detailed modeling. The results permitted a quick assessment of all possible radionuclidic contaminants and confirmed that the use of an energy degrader avoids production of the most important impurity, 88Zr. The estimated value for the activity produced in one hour of irradiation at 20 A is 384+42 MBq; t...
89Zr (T1/2 = 3.27 d) is an important β+-emitting radionuclide of zirconium used in immuno PET. The e...
Zirconium-89 (89Zr, t1/2 = 3.27 days) owns great potential in nuclear medicine, being extensively us...
Zirconium-89 (Zr-89) is an emerging radionuclide for positron emission tomography (PET), with nuclea...
none8The widely used Monte Carlo simulation code FLUKA has been utilized to prototype a solid target...
Zirconium-89 is a promising radionuclide in the development of new immuno-PET agents for in vivo ima...
The radionuclide zirconium-89 can be employed for the positron emission tomography (PET). In this st...
The Monte Carlo code FLUKA is used to simulate the production of a number of positron emitting radio...
Introduction Monte-Carlo simulations can be used to assess isotope production on small medical cyclo...
Zirconium 89 ($\text{}^{89}Zr$) is a promising radionuclide for development of new PET agents due to...
Zirconium 89 (89Zr) is a promising radionuclide for development of new PET agents due to its conveni...
Introduction Zr-89 is a useful radionuclide for radiolabeling proteins and other molecules.1,2 There...
In the context of hadron therapy, whilst ions are capable of effectively destroying radio resistant,...
The Monte Carlo toolkit Geant4 is used to simulate the production of a number of positron emitting r...
none10noBiomedical cyclotrons for production of Positron Emission Tomography (PET) radionuclides and...
The 89Zr is one of the most promising radionuclide in Nuclear Medicine for labelling monoclonal anti...
89Zr (T1/2 = 3.27 d) is an important β+-emitting radionuclide of zirconium used in immuno PET. The e...
Zirconium-89 (89Zr, t1/2 = 3.27 days) owns great potential in nuclear medicine, being extensively us...
Zirconium-89 (Zr-89) is an emerging radionuclide for positron emission tomography (PET), with nuclea...
none8The widely used Monte Carlo simulation code FLUKA has been utilized to prototype a solid target...
Zirconium-89 is a promising radionuclide in the development of new immuno-PET agents for in vivo ima...
The radionuclide zirconium-89 can be employed for the positron emission tomography (PET). In this st...
The Monte Carlo code FLUKA is used to simulate the production of a number of positron emitting radio...
Introduction Monte-Carlo simulations can be used to assess isotope production on small medical cyclo...
Zirconium 89 ($\text{}^{89}Zr$) is a promising radionuclide for development of new PET agents due to...
Zirconium 89 (89Zr) is a promising radionuclide for development of new PET agents due to its conveni...
Introduction Zr-89 is a useful radionuclide for radiolabeling proteins and other molecules.1,2 There...
In the context of hadron therapy, whilst ions are capable of effectively destroying radio resistant,...
The Monte Carlo toolkit Geant4 is used to simulate the production of a number of positron emitting r...
none10noBiomedical cyclotrons for production of Positron Emission Tomography (PET) radionuclides and...
The 89Zr is one of the most promising radionuclide in Nuclear Medicine for labelling monoclonal anti...
89Zr (T1/2 = 3.27 d) is an important β+-emitting radionuclide of zirconium used in immuno PET. The e...
Zirconium-89 (89Zr, t1/2 = 3.27 days) owns great potential in nuclear medicine, being extensively us...
Zirconium-89 (Zr-89) is an emerging radionuclide for positron emission tomography (PET), with nuclea...